1 active not recruiting, 1 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Terminated 1 |
| Phase 2 | 2 | Active not recruiting 1, Terminated 1 |
Follow Nephroma, Mesoblastic: new trials by email Literature Review of Nephroma, Mesoblastic trials Research Report on Nephroma, Mesoblastic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options Entrectinib - Solid Tumors, CNS Tumors | Phase 1 / Phase 2 | Active not recruiting | Hoffmann-La Roche | 69 | 2016-05-03 | 2026-09-23 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors carboplatin, dasatinib, etoposide phosphate - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 7 | 2008-09-03 | 2023-07-14 |
Central Nervous System Neoplasms (2) · Medulloblastoma (2) · Neuroblastoma (2) · Recurrence (2) · Sarcoma (2) · Wilms Tumor (2) · Astrocytoma (1) · Brain Neoplasms (1) · Burkitt Lymphoma (1) · Carcinoma, Renal Cell (1) · Choroid Plexus Neoplasms (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Familial ependymoma (1) · Glioma (1)
Adenocarcinoma (2) · Brain Diseases (2) · Carcinoma (2) · Central Nervous System Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Disease Attributes (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genetic Diseases, Inborn (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2)
Blotting, Western (1) · Carboplatin (1) · Dasatinib (1) · Ifosfamide (1) · Immunohistochemistry (1) · Microarray Analysis (1) · Radiotherapy (1) · entrectinib (1) · etoposide phosphate (1)
City of Hope Medical Center (1) · Hoffmann-La Roche (1)
United States (2) · Canada (1) · China (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · Spain (1) · United Kingdom (1)
PMID 31838007, PMID 35395680, PMID 40086048
2023 (1), P30CA033572 (1)